Vertex's Journavx got FDA approval for acute pain but faces adoption challenges. Click here to read more about VRTX stock and ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

The FDA has approved a new non-opioid prescription medication, Journavx for adults with moderate to severe acute pain.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

A participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous Brenton Blanchet is a writer-reporter at PEOPLE. He has been working at PEOPLE ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

A new painkiller was approved by the Food and Drug Administration (FDA) on Thursday, and is one step closer to making its way ...